摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-二甲基-4-庚酮 | 19549-84-9

中文名称
3,5-二甲基-4-庚酮
中文别名
——
英文名称
3-butyl ketone
英文别名
di-sec-butyl ketone;3,5-dimethyl-4-heptanone;methyl-n-propyl ketone;3,5-dimethyl-heptan-4-one;3,5-Dimethyl-heptan-4-on;α.α-Dimethyl-α.α'-diaethyl-aceton;methyl-propyl ketone;Di-sek.-butyl-keton;3,5-Dimethylheptan-4-one
3,5-二甲基-4-庚酮化学式
CAS
19549-84-9
化学式
C9H18O
mdl
——
分子量
142.241
InChiKey
VZXXYILNWWRSGE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    -18.52°C (estimate)
  • 沸点:
    162 °C
  • 密度:
    0.826
  • 闪点:
    46 °C
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    10
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险等级:
    3.2
  • 安全说明:
    S16
  • 危险类别码:
    R10
  • 海关编码:
    2914190090
  • 包装等级:
    III
  • 危险类别:
    3.2
  • 危险品运输编号:
    UN 1224
  • 储存条件:
    应存放在阴凉干燥处。

SDS

SDS:627bf45ed272a8feac4261012ca1f38e
查看
Name: 3 5-Dimethyl-4-heptanone 97+% Material Safety Data Sheet
Synonym:
CAS: 19549-84-9
Section 1 - Chemical Product MSDS Name:3 5-Dimethyl-4-heptanone 97+% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
19549-84-9 3,5-Dimethyl-4-heptanone 97+ 243-150-4
Hazard Symbols: None Listed.
Risk Phrases: 10

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Flammable.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. May cause chemical conjunctivitis and corneal damage.
Skin:
May cause irritation and dermatitis. May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated. Ingestion of large amounts may cause CNS depression.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Aspiration may lead to pulmonary edema. Vapors may cause dizziness or suffocation.
May cause burning sensation in the chest.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Vapors may form an explosive mixture with air.
Vapors can travel to a source of ignition and flash back. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Will burn if involved in a fire. Use water spray to keep fire-exposed containers cool. Water may be ineffective. Material is lighter than water and a fire may be spread by the use of water. Containers may explode in the heat of a fire.
Flammable liquid and vapor. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas.
Extinguishing Media:
For small fires, use dry chemical, carbon dioxide, water spray or alcohol-resistant foam. For large fires, use water spray, fog, or alcohol-resistant foam. Use water spray to cool fire-exposed containers. Water may be ineffective. Use agent most appropriate to extinguish fire. Do NOT use straight streams of water.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section. Remove all sources of ignition. Use a spark-proof tool. Provide ventilation. A vapor suppressing foam may be used to reduce vapors.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Ground and bond containers when transferring material. Use spark-proof tools and explosion proof equipment. Avoid contact with eyes, skin, and clothing. Empty containers retain product residue, (liquid and/or vapor), and can be dangerous. Keep container tightly closed. Keep away from heat, sparks and flame. Avoid ingestion and inhalation. Do not pressurize, cut, weld, braze, solder, drill, grind, or expose empty containers to heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Flammables-area.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local explosion-proof ventilation to keep airborne levels to acceptable levels.
Exposure Limits CAS# 19549-84-9: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: clear, colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 162 deg C @ 760.00 mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: 46 deg C ( 114.80 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 0.8260 g/cm3
Molecular Formula: C9H18O
Molecular Weight: 142.24

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong bases, strong oxidizing agents, strong reducing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 19549-84-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3,5-Dimethyl-4-heptanone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: KETONES, LIQUID, N.O.S.*
Hazard Class: 3
UN Number: 1224
Packing Group: III
IMO
Shipping Name: KETONES, LIQUID, N.O.S.
Hazard Class: 3.3
UN Number: 1224
Packing Group: III
RID/ADR
Shipping Name: KETONES, N.O.S.
Hazard Class: 3
UN Number: 1224
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
R 10 Flammable.
Safety Phrases:
S 9 Keep container in a well-ventilated place.
S 16 Keep away from sources of ignition - No
smoking.
S 28A After contact with skin, wash immediately with
plenty of water.
S 33 Take precautionary measures against static
discharges.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 19549-84-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 19549-84-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 19549-84-9 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,5-二甲基-4-庚酮乙醚 、 sodium amide 、 作用下, 生成 3-ethyl-3,4,5-trimethyl-heptan-4-ol
    参考文献:
    名称:
    Nasarow, Chemische Berichte, 1937, vol. 70, p. 620
    摘要:
    DOI:
  • 作为产物:
    描述:
    参考文献:
    名称:
    Lion,C.; Dubois,J.-E., Bulletin de la Societe Chimique de France, 1973, p. 2673 - 2676
    摘要:
    DOI:
  • 作为试剂:
    描述:
    1-碘-15-甲基-十六烷 、 3羰基茚酯酸甲酯3,5-二甲基-4-庚酮potassium carbonate 作用下, 生成 32-methyl-tritriacontan-16-one
    参考文献:
    名称:
    Staellberg-Stenhagen; Stenhagen, Journal of Biological Chemistry, 1948, vol. 173, p. 398
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] MYCOPHENOLIC ACID RECYCLING IN A METHOD FOR THE PREPARATION OF MYCOPHENOLATE MOFETIL<br/>[FR] RECYCLAGE D'ACIDE MYCOPHÉNOLIQUE DANS UN PROCÉDÉ DE PRÉPARATION DE MYCOPHÉNOLATE MOFÉTIL
    申请人:DSM IP ASSETS BV
    公开号:WO2009010503A1
    公开(公告)日:2009-01-22
    The present invention provides a method for the preparation of mycophenolate mofetil wherein mycophenoiic acid is mixed with 2-morpholinoethanol in a water-immiscible solvent, followed by addition of water and adjustment of the pH to a value ranging from 0 to 3 or ranging from 7 to 10 and separating the organic and aqueous phases. Mycophenolate mofetil is isolated from the relevant phase and the mycophenoiic acid present in the alternate phase is re-used in a conversion of mycophenoiic acid to mycophenolate mofetil.
    本发明提供了一种制备霉酚酸酯的方法,其中将霉酚酸与2-吗啉乙醇混合在不溶于水的溶剂中,然后加入水并将pH值调整到0至3或7至10之间,并分离有机相和水相。从相关相中分离出霉酚酸酯,并将另一相中存在的霉酚酸重新用于将霉酚酸转化为霉酚酸酯。
  • Catalyst composition for hydrogenation and method for hydrogenation using the same
    申请人:Asahi Kasei Chemicals Corporation
    公开号:US10016749B2
    公开(公告)日:2018-07-10
    A catalyst composition for hydrogenation including (A) to (D), in which a mass ratio ((C)/(A)) is 0.1 to 4.0 and a mass ratio ((D)/(A)) is 0.01 to 1.00, (A): a titanocene compound represented by formula (1), (wherein R5 and R6 are any group selected from hydrogen, a hydrocarbon group having 1 to 12 carbon atoms, an aryloxy group, an alkoxy group, a halogen group, and a carbonyl group. R1 and R2 are any group selected from the group consisting of hydrogen and a hydrocarbon group having 1 to 12 carbon atoms, and R1 and R2 are not all hydrogen atoms or all a hydrocarbon group having 1 to 12 carbon atoms), (B): a reductant formed from a compound containing an element selected from the elements Li, Na, K, Mg, Zn, Al, and Ca, (C): an unsaturated compound having a molecular weight of 400 or less, and (D): a polar compound.
    一种用于加氢的催化剂组合物,包括(A)至(D),其中质量比((C)/(A))为0.1至4.0,质量比((D)/(A))为0.01至1.00, (A):由公式(1)表示的钛环戊二烯基化合物, (其中R5和R6是从氢、具有1至12个碳原子的烃基、芳氧基、烷氧基、卤素基和羰基中选择的任何基团。R1和R2是从氢和具有1至12个碳原子的烃基组成的组中选择的任何基团,且R1和R2不全是氢原子或全部为具有1至12个碳原子的烃基), (B):由含有选自Li、Na、K、Mg、Zn、Al和Ca元素的化合物的还原剂形成, (C):分子量400或以下的非饱和化合物,以及 (D):极性化合物。
  • Palladium(II)-Catalyzed Site-Selective C(sp<sup>3</sup> )−H Alkynylation of Oligopeptides: A Linchpin Approach for Oligopeptide-Drug Conjugation
    作者:Tao Liu、Jennifer X. Qiao、Michael A. Poss、Jin-Quan Yu
    DOI:10.1002/anie.201706367
    日期:2017.8.28
    C(sp3)−H alkynylation of oligopeptides was developed with tetrabutylammonium acetate as a key additive. Through molecular design, the acetylene motif served as a linchpin to introduce a broad range of carbonyl‐containing pharmacophores onto oligopeptides, thus providing a chemical tool for the synthesis and modification of novel oligopeptide–pharmacophore conjugates by C−H functionalization. Dipeptide
    以乙酸四丁基铵为关键添加剂,开发了钯 (II) 催化的寡肽 C(sp 3 )−H 炔基化反应。通过分子设计,乙炔基序作为关键,将多种含羰基的药效团引入到寡肽上,从而为通过CH官能化合成和修饰新型寡肽-药效团缀合物提供了化学工具。通过该方法合成了与粪甾烷醇和雌二醇的二肽缀合物,其在向核激素受体过度表达的肿瘤细胞靶向药物递送方面具有潜在的应用。
  • Aspartates containing ketimine-groups and their use in coating compositions
    申请人:Bayer MaterialScience LLC
    公开号:EP1518852A1
    公开(公告)日:2005-03-30
    The present invention relates to novel aspartates, their method of production and the use of these aspartates as reactive components for polyisocyanates in two-component polyurethane coating compositions and for preparing polyurethane prepolymers. The aspartaes are prepared by first reacting a di- or polyamine with an unsaturated ester and then reacting the resultant product with a ketone.
    本发明涉及新型天冬氨酸盐,其生产方法以及将这些天冬氨酸盐作为双组分聚氨酯涂料组合物中聚异氰酸酯的反应组分和制备聚氨酯预聚物的用途。这些天冬氨酸盐是通过首先将二元或多元胺与不饱和酯反应,然后将所得产物与酮反应制备而成的。
  • [EN] METAL ORGANIC COMPOUNDS<br/>[FR] COMPOSÉS ORGANOMÉTALLIQUES
    申请人:UMICORE AG & CO KG
    公开号:WO2021197597A1
    公开(公告)日:2021-10-07
    The invention concerns a process for preparing an essentially silicon (Si) free compounds of the general formula [M(O)(OR)y], wherein M = Mo, y = 3 or M = W, y = 3 or 4. Furthermore, it is directed towards compounds obtained by the aforementioned process and towards the use of such an obtained compound. Another objective of the herein described invention are essentially silicon free compounds of the general formula MOXy or [MOXy(solv)p], prepared using the aforementioned process, wherein M = Mo, y = 3 or M = W, y = 3 or 4, X = Cl or Br, solv = an oxidizing agent Z binding or coordinating to M via at least one donor atom, p = 1 or 2. The invention is also directed towards the use of essentially silicon free compounds prepared using the aforementioned process of the general formula MOXy or [MOXy(solv)p].
    该发明涉及一种制备通式[M(O)(OR)y]的基本无硅(Si)化合物的过程,其中M = Mo,y = 3或M = W,y = 3或4。此外,它针对通过上述过程获得的化合物以及利用这种获得的化合物的用途。所述发明的另一个目标是使用上述过程制备的通式MOXy或[MOXy(solv)p]的基本无硅化合物,其中M = Mo,y = 3或M = W,y = 3或4,X = Cl或Br,solv = 通过至少一个供体原子与M结合或配位的氧化剂Z,p = 1或2。该发明还涉及利用利用上述通式MOXy或[MOXy(solv)p]的基本无硅化合物的方法。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台